Conclusion With continuous breakthroughs in oral GLP-1 therapies, oral GLP-1 drug development trends are driving a new growth cycle in the global metabolic disease treatment landscape
Listen on your device:RECOMMENDED These links will only work if you're on the device you listen to podcasts on
You might see patches of missing hair on the scalp, eyebrows, eyelashes, or other body areas
Meetings remain free and nonjudgmental, not to mention confidential
Tirzepatide (Zepbound, Mounjaro) Tirzepatide works similarly to semaglutide, but in addition to mimicking GLP-1, tirzepatide also mimics the hormone GIP (which stands for glucose-dependent insulinotropic polypeptide)
Warnings Wegovy may not be suitable for everyone